Plus   Neg

Stock Alert: Sorrento Therapeutics Uptick Continues

Shares of Sorrento Therapeutics, Inc. (SRNE) are currently gaining 17% on Friday morning, continuing its upward momentum from Thursday.

The biotech company on Wednesday had announced the launch of a rapid diagnostic saliva COVID-19 test that reveals results in 30 minutes.

SRNE is currently trading at $10.03, up $1.48 or 17.31%, on the Nasdaq.

The company said it licensed the Covid-19 from Columbia University that can provide highly accurate results in thirty minutes using only a person's saliva.

Developed by the team at Columbia University Irving Medical Center (CUIMC), initial clinical studies have been extremely promising for both specificity and sensitivity.
Sorrento plans to market the product under the name COVI-TRACE.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Despite the coronavirus pandemic, retailers are prepared for an early start to the holiday shopping season by offering discounts earlier so that consumers can buy and receive the gifts they want in time, the National Retail Federation or NRF said. The NRF also said it is launching a nationwide consumer education campaign called "New Holiday Traditions". Facebook (FB) has revealed new messaging features for Instagram, which will make it easier for users to stay in touch with others across Facebook's family of apps. The main change is that people using the Messenger app can now reach Instagram users, and vice versa. The users can control where they receive... Regeneron Pharmaceuticals, Inc. announced positive first data from a descriptive analysis of a seamless Phase 1/2/3 trial of its investigational antibody cocktail REGN-COV2 in COVID-19 patients. REGN-COV2 rapidly reduced viral load and associated symptoms in infected COVID-19 patients. The company said it plans rapidly to discuss results with regulatory authorities.
Follow RTT